A method for detecting nadroparin calcium products
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- 广东三生制药有限公司
- Publication Date
- 2016-01-20
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
Technical field
[0001] The invention relates to the technical field of ultraviolet-visible spectrophotometric detection, in particular to a method for rapidly detecting nadroparin calcium products. Background technique
[0002] Heparin drugs are highly sulfated mucopolysaccharide sulfates, which are widely used in the treatment of cardiovascular and cerebrovascular diseases and hemodialysis. Among them, it is currently the only specific drug available in the treatment of severe hemodialysis. Currently, low molecular weight heparin (LMWH), which is a heparin derivative with an average molecular weight distribution of 3500-6500Da, is dominant in the heparin drug market. Because compared with unfractionated heparin (UFH), LMWH has many obvious clinical application advantages, including clearer pharmacological effects, greatly reduced side effects, long duration of antithrombotic activity, and higher bioavailability. There are mainly 5 kinds of common LMWH preparations, namely Nadro...